7 Sep
2021

Pfizer: light on patent filings and heavy on abandonments

Pfizer has decided that patent portfolio streamlining is one way to free up resources, but it also monetises its de-prioritised inventions

Bridget Diakun

Author | Data reporter

[email protected]